The Pelotonia Institute for Immuno-Oncology
The next frontier in cancer research
The Pelotonia Institute for Immuno-Oncology was established in 2019 with an initial pledge of $102,265,000 from the Pelotonia community.
Led by inaugural Director Dr. Zihai Li, this research initiative focuses on harnessing the body’s immune system to fight cancer at all levels. The PIIO has achieved the following milestones:
- • Launched 99 human clinical trials
- • Obtained $32 million in annual funding from new grants
- • Assisted in immunotherapeutic studies relating to the COVID-19 pandemic
- • Published more than 500 peer-reviewed articles
Led by inaugural Director Dr. Zihai Li, this research initiative focuses on harnessing the body’s immune system to fight cancer at all levels. The PIIO has achieved the following milestones:
More about The Institute
One Goal Podcast on Immuno-oncology
Dr. Zihai Li and Dr. David Carbone discuss immuno-oncology and its importance.
Listen
Annual Report
A comprehensive look at the PIIO's progress in accomplishing its goals in talent, research, honors and resources.
Download and Share
The new home of the PIIO, the Pelotonia Research Center, has been named in honor of the Pelotonia community's ongoing impact. Watch the video below to learn more!
Watch Now450 W. Broad Street, Columbus, OH | 614.221.6100
© 2024 Pelotonia. All rights reserved.
Major Funding Partners
